Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.

Cristian D ValenzuelaIan B SolskyRichard A EraliSteven D ForsytheChristopher W MangieriBigyan B MainaliGregory RussellKathleen C PerryKonstantinos I VotanopoulosPerry ShenEdward A Levine

Published in: Annals of surgical oncology (2023)

This represents one of the largest and lengthiest, single-center, longitudinal, case series of peritoneal mesothelioma treated with CRS-HIPEC. The OS suggests efficacy for CRS-HIPEC for MPM. Long-term survival improves significantly after patients achieve the 1-year, postoperative mark.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
patients undergoing
peritoneal dialysis
prognostic factors
squamous cell carcinoma
cross sectional
patient reported outcomes
chemotherapy induced